3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
4
Active not recruiting
3
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Rectal Neoplasms
11
Glioblastoma
10
Breast Neoplasms
10
Lung Neoplasms
9
Head and Neck Neoplasms
8
Neoplasms
6
Neoplasm Metastasis
6
Brain Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Prostatic Neoplasms
5
Leukemia
4
Gliosarcoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Carcinoma, Merkel Cell
3
Adenocarcinoma Of Esophagus
3
Xerostomia
2
Waldenstrom Macroglobulinemia
2
Small Cell Lung Carcinoma
2
Recurrence
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Interventions
pembrolizumab
20
Carboplatin
14
Cyclophosphamide
12
atezolizumab
11
Paclitaxel
10
Albumin-Bound Paclitaxel
8
Capecitabine
7
Nivolumab
6
130-nm albumin-bound paclitaxel
6
spartalizumab
5
fludarabine
5
Taxes
5
Gemcitabine
5
talazoparib
4
bintrafusp alfa protein, human
4
avelumab
4
Cisplatin
4
sacituzumab govitecan
3
olaparib
3
entinostat
3
Leucovorin
3
Ipilimumab
3
Immunoglobulin G
3
Drug Therapy
3
Doxorubicin
3
Docetaxel
3
Biopsy
3
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
3
trilaciclib
2
eribulin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Triple Negative Breast Neoplasms
×
Radiation
×
Clear all
NCT04690855
2023-12-04
TARA
Hoosier Cancer Research Network
Phase 2
Terminated
1 enrolled
11 charts